Hematological Profiles and Clinical Outcome of COVID-19 Among Patients Admitted at Debre Markos Isolation and Treatment Center, 2020: A Prospective Cohort Study

References

• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–733. doi:10.1056/NEJMoa2001017
   PubMed Web of Science ®Google Scholar
• Ciotti M, Angeletti S, Minieri M, et al. COVID-19 outbreak: an overview. Chemotherapy. 2019;64(5–6):215–223. doi:10.1159/000507423
   PubMed Web of Science ®Google Scholar
• Wu F, Zhao S, Yu B, et al. Complete genome characterisation of a novel coronavirus associated with severe human respiratory disease in Wuhan, China. bioRxiv. 2020;2020:1.
   Google Scholar
• Dong N, Yang X, Ye L, Chen K, Chan EWC, Chen S. Genomic and protein structure modelling analysis depicts the origin and pathogenicity of 2019-nCoV, a new coronavirus which caused a pneumonia outbreak in Wuhan, China. F1000Research. 2020;9(121):121. doi:10.12688/f1000research.22357.2
   Google Scholar
• Cui J, Li F, Shi Z-L. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17(3):181–192. doi:10.1038/s41579-018-0118-9
   PubMed Web of Science ®Google Scholar
• Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: origin, transmission, and characteristics of human coronaviruses. J Adv Res. 2020;24:91–98. doi:10.1016/j.jare.2020.03.005
   PubMed Web of Science ®Google Scholar
• Phan LT, Nguyen TV, Luong QC, et al. Importation and human-to-human transmission of a novel coronavirus in Vietnam. N Engl J Med. 2020;382(9):872–874. doi:10.1056/NEJMc2001272
   PubMed Web of Science ®Google Scholar
• Riou J, Althaus CL. Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020. Eurosurveillance. 2020;25(4):2000058. doi:10.2807/1560-7917.ES.2020.25.4.2000058
   Web of Science ®Google Scholar
• Parry J. China coronavirus: cases surge as official admits human to human transmission. Br Med J. 2020;m236. doi:10.1136/bmj.m236
   PubMed Web of Science ®Google Scholar
• Upadhyay J, Tiwari N, Ansari MN. Role of inflammatory markers in Corona virus disease (COVID-19) patients: a review. Exp Biol Med. 2020;245(15):1368–1375. doi:10.1177/1535370220939477
   PubMed Web of Science ®Google Scholar
• Lin L, Lu L, Cao W, Li T. Hypothesis for potential pathogenesis of SARS-CoV-2 infection–a review of immune changes in patients with viral pneumonia. Emerg Microbes Infec. 2020;9(1):727–732. doi:10.1080/22221751.2020.1746199
   PubMed Web of Science ®Google Scholar
• Ding Y, He L, Zhang Q, et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS‐CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol. 2004;203(2):622–630. doi:10.1002/path.1560
   PubMed Web of Science ®Google Scholar
• Klok F, Kruip M, Van der Meer N, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145–147.
   PubMed Web of Science ®Google Scholar
• Filatov A, Sharma P, Hindi F, Espinosa PS. Neurological complications of coronavirus disease (COVID-19): encephalopathy. Cureus. 2020;12:1.
   Web of Science ®Google Scholar
• Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5:802. doi:10.1001/jamacardio.2020.0950
   PubMed Web of Science ®Google Scholar
• Bairwa M, Kumar R, Beniwal K, Kalita D, Bahurupi Y. Hematological profile and biochemical markers of COVID-19 non-survivors: a retrospective analysis. Clin Epidemiol Glob Health. 2021;11:100770. doi:10.1016/j.cegh.2021.100770
   PubMed Web of Science ®Google Scholar
• Roy D, Ghosh R, Dubey S, Dubey MJ, Benito-León J, Ray BK. Neurological and neuropsychiatric impacts of COVID-19 pandemic. Can J Neurol Sci. 2021;48(1):9–24. doi:10.1017/cjn.2020.173
   PubMed Web of Science ®Google Scholar
• Kitamura Y, Karkour S, Ichisugi Y, Itsubo N. Evaluation of the economic, environmental, and social impacts of the COVID-19 pandemic on the Japanese tourism industry. Sustainability. 2020;12(24):10302. doi:10.3390/su122410302
   Web of Science ®Google Scholar
• Cheval S, Mihai Adamescu C, Georgiadis T, Herrnegger M, Piticar A, Legates DR. Observed and potential impacts of the COVID-19 pandemic on the environment. Int J Environ Res Public Health. 2020;17(11):4140. doi:10.3390/ijerph17114140
   PubMed Web of Science ®Google Scholar
• Araya S, Wordofa M, Mamo MA, et al. The magnitude of hematological abnormalities among COVID-19 patients in Addis Ababa, Ethiopia. J Multidiscip Healthc. 2021;14:545. doi:10.2147/JMDH.S295432
   PubMed Web of Science ®Google Scholar
• Rahman A, Niloofa R, Jayarajah U, De Mel S, Abeysuriya V, Seneviratne SL. Hematological abnormalities in COVID-19: a narrative review. Am J Trop Med Hyg. 2021;104(4):1188. doi:10.4269/ajtmh.20-1536
   PubMed Web of Science ®Google Scholar
• Yuan X, Huang W, Ye B, et al. Changes of hematological and immunological parameters in COVID-19 patients. Int J Hematol. 2020;112(4):553–559. doi:10.1007/s12185-020-02930-w
   PubMed Web of Science ®Google Scholar
• Lippi G, Mattiuzzi C. Hemoglobin value may be decreased in patients with severe coronavirus disease 2019. Hematol Transfus Cell Ther. 2020;42:116–117. doi:10.1016/j.htct.2020.03.001
   PubMedGoogle Scholar
• Gujar RK, Meena A, Chouhan SS, Likhar K. Hematological profiles of COVID-19 patients at the Ratlam district, Madhya Pradesh State, India. Bioinformation. 2021;17(7):686. doi:10.6026/97320630017686
   PubMed Web of Science ®Google Scholar
• Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi:10.1016/S0140-6736(20)30211-7
   PubMed Web of Science ®Google Scholar
• Shenoy N, Luchtel R, Gulani P. Considerations for target oxygen saturation in COVID-19 patients: are we under-shooting? BMC Med. 2020;18(1):1–6. doi:10.1186/s12916-020-01735-2
   PubMed Web of Science ®Google Scholar
• Mao J, Dai R, Du R-C, Zhu Y, Shui L-P, Luo X-H. Hematologic changes predict clinical outcome in recovered patients with COVID-19. Ann Hematol. 2021;100(3):675–689. doi:10.1007/s00277-021-04426-x
   PubMed Web of Science ®Google Scholar
• Xu R, Cui B, Duan X, Zhang P, Zhou X, Yuan Q. Saliva: potential diagnostic value and transmission of 2019-nCoV. Int J Oral Sci. 2020;12(1):1–6. doi:10.1038/s41368-020-0080-z
   PubMed Web of Science ®Google Scholar
• Tan L, Wang Q, Zhang D, et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct Target Ther. 2020;5(1):1–3. doi:10.1038/s41392-019-0089-y
   PubMed Web of Science ®Google Scholar
• Huang I, Pranata R. Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis. J Intensive Care. 2020;8(1):36. doi:10.1186/s40560-020-00453-4
   PubMed Web of Science ®Google Scholar
• Bhattacharjee S, Banerjee M. Immune thrombocytopenia secondary to COVID-19: a systematic review. SN Compr Clin Med. 2020;2(11):2048–2058. doi:10.1007/s42399-020-00521-8
   PubMedGoogle Scholar
• Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Anal Chim Acta. 2020;506:145–148. doi:10.1016/j.cca.2020.03.022
   Web of Science ®Google Scholar
• Yang X, Yang Q, Wang Y, et al. Thrombocytopenia and its association with mortality in patients with COVID‐19. J Thromb Haemost. 2020;18(6):1469–1472. doi:10.1111/jth.14848
   PubMed Web of Science ®Google Scholar
• Bellmann-Weiler R, Lanser L, Barket R, et al. Prevalence and predictive value of anemia and dysregulated iron homeostasis in patients with COVID-19 infection. J Clin Med. 2020;9(8):2429. doi:10.3390/jcm9082429
   PubMed Web of Science ®Google Scholar
• Bergamaschi G, Borrelli de Andreis F, Aronico N, et al. Anemia in patients with Covid-19: pathogenesis and clinical significance. Clin Exp Med. 2021;21(2):239–246. doi:10.1007/s10238-020-00679-4
   PubMed Web of Science ®Google Scholar
• Zuin M, Rigatelli G, Quadretti L, Fogato L, Zuliani G, Roncon L. Prognostic role of anemia in COVID-19 patients: a meta-analysis; infect. Dis Rep. 2021;13:930–937. doi:10.3390/idr13040085
   Web of Science ®Google Scholar
• World Health Organization. Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity. Geneva: World Health Organization; 2011.
   Google Scholar
• Al-kuraishy HM, Al-Gareeb AI, Kaushik A, Kujawska M, Batiha GES. Hemolytic anemia in COVID-19. Ann Hematol. 2022;101(9):1887–1895. doi:10.1007/s00277-022-04907-7
   PubMed Web of Science ®Google Scholar
• Turk C, Turk S, Malkan U, Haznedaroglu IC. Three critical clinicobiological phases of the human SARS-associated coronavirus infections; 2020.
   Google Scholar